Locations:
Search IconSearch
April 4, 2022/Neurosciences/Podcast

Epilepsy Surgery: An Underused Treatment Option (Podcast)

Surgery can be a game changer when medications fail to control seizures

Epilepsy surgery is a viable treatment option when more than two appropriately prescribed medications fail to control seizures. However, it remains significantly underutilized.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Every patient is a surgical candidate once they fail a couple of medicines,” says William Bingaman, MD, Vice Chair of Cleveland Clinic’s Neurological Institute and Director of the Epilepsy Surgery Program in its Charles Shor Epilepsy Center. “The trick then is just to be able to tell patients what their chances are to become seizure free so they can drive, work or even just take a bath or shower by themselves without fear of drowning.”

In the latest episode of Cleveland Clinic’s Neuro Pathways podcast, Dr. Bingaman discusses the state of epilepsy surgery and its value in the care of individuals with uncontrolled epilepsy. He touches on:

  • The evolution of epilepsy surgery
  • Factors that contribute to low surgical referrals
  • Types of epilepsy procedures, including resection, palliative surgery and laser ablation
  • The role of magnetoencephalography and imaging modalities
  • The future of epilepsy surgery and drug delivery into the brain

Click the podcast player above to listen to the episode now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

This activity has been approved for AMA PRA Category 1 Credit™. After listening to the podcast, you can claim your credit here.

Excerpt from the episode

Podcast host Glen Stevens, DO, PhD: The great news is that there are a lot of epilepsy drugs out there now, versus when you and I started to practice. In some ways, the bad news is that there are a lot of epilepsy drugs out there. It becomes easy for neurologists to say, “Well, let’s try this new drug,” doesn’t it?

Advertisement

Dr. Bingaman: It could take 10 or 15 years probably to go through all the drugs on a fair trial. It reminds me of a patient I saw last year who came up from central Ohio. She was in her late 60s, and she had hippocampal sclerosis, the most common adult epilepsy we see and also the type that responds most successfully to epilepsy surgery. She had a febrile convulsion as a baby. At 15, she started having seizures and had been seizing for 50 years.

She and her husband were sitting in my clinic and we were talking about temporal lobectomy, which we typically don’t do on people in their 60s. Occasionally we do, but it’s rare. So I said, “Gosh, you’ve had seizures for 50-some years. Why now? Why are you here now?” And she looked at me and said, “Well, I didn’t know surgery was an option.” … That’s unfortunately something we still see, and 50 years of uncontrolled epilepsy can really do a number on someone.

Advertisement

Related Articles

gamma knife machine

Stereotactic Radiosurgery Shows Strong Local Control in SCLC Brain Metastases

Adequate dosing may improve outcomes in well-selected patients, large Cleveland Clinic series suggests

portrait of Dr. Robert Bermel against a decorative backdrop with podcast icon overlay
July 2, 2026/Neurosciences/Podcast

Inside Our New Neurological Assessment Center (Podcast)

Reimagining the outpatient neurological visit with routine capture of neuroperformance data

woman in white medical coat typing on a laptop in lab setting
June 30, 2026/Neurosciences/Epilepsy

Online Tool Makes It Easier to Share and Analyze Data on Epilepsy-Related Cognitive Disorders

Free portal helps researchers classify and share data using the IC-CoDE framework

woman in wheelchair being wheeled into or out of an elevator

Key Rural-Urban Differences Revealed in U.S. Post-Acute Stroke Care

Large study shows rural patients are less apt to be discharged to inpatient rehab, hampering outcomes

portrait of Dr. Jeffrey Cohen against decorative background with podcast icon overlay
June 16, 2026/Neurosciences/Podcast

The Potential of CAR T-Cell Therapy in Multiple Sclerosis (Podcast)

Updates on this fast-evolving therapeutic landscape from a leading trialist

rendering of a two-tower medical building

New Building to Showcase the Potential of a Hybrid OR in Neurosurgery Care

Advanced surgical suite in our soon-to-open facility promises to redefine care standards

middle-aged woman looking down sadly while sitting on a bed

Multiple Sclerosis Progression in Midlife Women: Disentangling Reproductive and Somatic Aging

Two research projects aim to enable more personalized MS care in this population

medical team rushing patient on gurney through hospital hallway

Even With Gains in Quality Metrics, Inpatient Stroke Care Lags Community Stroke Care

Inferior clinical outcomes continue into mechanical thrombectomy era, large analysis finds

Ad